vs
Custom Truck One Source, Inc.（CTOS）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是Custom Truck One Source, Inc.的1.2倍（$493.8M vs $422.2M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs -4.2%，领先11.0%），Pediatrix Medical Group, Inc.同比增速更快（-1.7% vs -8.5%），过去两年Custom Truck One Source, Inc.的营收复合增速更高（14.8% vs -0.1%）
Custom Truck One Source是北美领先的专用重型卡车及设备解决方案提供商，业务覆盖定制车辆制造、设备销售与租赁、售后配件供应及维保服务，主要服务基建、公用事业、建筑、能源等核心领域。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
CTOS vs MD — 直观对比
营收规模更大
MD
是对方的1.2倍
$422.2M
营收增速更快
MD
高出6.8%
-8.5%
净利率更高
MD
高出11.0%
-4.2%
两年增速更快
CTOS
近两年复合增速
-0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $422.2M | $493.8M |
| 净利润 | $-17.8M | $33.7M |
| 毛利率 | 20.3% | — |
| 营业利润率 | 2.9% | 9.9% |
| 净利率 | -4.2% | 6.8% |
| 营收同比 | -8.5% | -1.7% |
| 净利润同比 | -333.7% | 10.5% |
| 每股收益（稀释后） | $-0.08 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTOSMD
| Q1 26 | $422.2M | — | ||
| Q4 25 | $387.3M | $493.8M | ||
| Q3 25 | $359.9M | $492.9M | ||
| Q2 25 | $392.2M | $468.8M | ||
| Q1 25 | $307.1M | $458.4M | ||
| Q4 24 | $398.3M | $502.4M | ||
| Q3 24 | $337.5M | $511.2M | ||
| Q2 24 | $320.6M | $504.3M |
净利润CTOSMD
| Q1 26 | $-17.8M | — | ||
| Q4 25 | $20.9M | $33.7M | ||
| Q3 25 | $-5.8M | $71.7M | ||
| Q2 25 | $-28.4M | $39.3M | ||
| Q1 25 | $-17.8M | $20.7M | ||
| Q4 24 | $27.6M | $30.5M | ||
| Q3 24 | $-17.4M | $19.4M | ||
| Q2 24 | $-24.5M | $-153.0M |
毛利率CTOSMD
| Q1 26 | 20.3% | — | ||
| Q4 25 | 31.8% | — | ||
| Q3 25 | 28.0% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 27.9% | — | ||
| Q4 24 | 29.7% | — | ||
| Q3 24 | 27.2% | — | ||
| Q2 24 | 27.8% | — |
营业利润率CTOSMD
| Q1 26 | 2.9% | — | ||
| Q4 25 | 13.4% | 9.9% | ||
| Q3 25 | 9.1% | 13.8% | ||
| Q2 25 | 7.1% | 12.8% | ||
| Q1 25 | 4.0% | 7.0% | ||
| Q4 24 | 16.9% | 7.8% | ||
| Q3 24 | 6.8% | 6.6% | ||
| Q2 24 | 5.5% | -31.3% |
净利率CTOSMD
| Q1 26 | -4.2% | — | ||
| Q4 25 | 5.4% | 6.8% | ||
| Q3 25 | -1.6% | 14.5% | ||
| Q2 25 | -7.2% | 8.4% | ||
| Q1 25 | -5.8% | 4.5% | ||
| Q4 24 | 6.9% | 6.1% | ||
| Q3 24 | -5.2% | 3.8% | ||
| Q2 24 | -7.6% | -30.3% |
每股收益（稀释后）CTOSMD
| Q1 26 | $-0.08 | — | ||
| Q4 25 | $0.10 | $0.40 | ||
| Q3 25 | $-0.03 | $0.84 | ||
| Q2 25 | $-0.13 | $0.46 | ||
| Q1 25 | $-0.08 | $0.24 | ||
| Q4 24 | $0.11 | $0.37 | ||
| Q3 24 | $-0.07 | $0.23 | ||
| Q2 24 | $-0.10 | $-1.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.3M | $375.2M |
| 总债务越低越好 | $25.9M | $570.5M |
| 股东权益账面价值 | $809.1M | $865.9M |
| 总资产 | $3.4B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.03× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资CTOSMD
| Q1 26 | $6.3M | — | ||
| Q4 25 | $6.3M | $375.2M | ||
| Q3 25 | $13.1M | $340.1M | ||
| Q2 25 | $5.3M | $224.7M | ||
| Q1 25 | $5.4M | $99.0M | ||
| Q4 24 | $3.8M | $229.9M | ||
| Q3 24 | $8.4M | $103.8M | ||
| Q2 24 | $8.1M | $19.4M |
总债务CTOSMD
| Q1 26 | $25.9M | — | ||
| Q4 25 | $1.6B | $570.5M | ||
| Q3 25 | $1.6B | $577.2M | ||
| Q2 25 | $1.6B | $583.9M | ||
| Q1 25 | $1.6B | $590.5M | ||
| Q4 24 | $1.5B | $597.1M | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.5B | — |
股东权益CTOSMD
| Q1 26 | $809.1M | — | ||
| Q4 25 | $809.1M | $865.9M | ||
| Q3 25 | $784.7M | $890.7M | ||
| Q2 25 | $790.1M | $833.8M | ||
| Q1 25 | $813.4M | $789.2M | ||
| Q4 24 | $861.3M | $764.9M | ||
| Q3 24 | $837.5M | $732.5M | ||
| Q2 24 | $856.7M | $706.5M |
总资产CTOSMD
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $2.2B | ||
| Q3 25 | $3.5B | $2.2B | ||
| Q2 25 | $3.6B | $2.1B | ||
| Q1 25 | $3.5B | $2.0B | ||
| Q4 24 | $3.5B | $2.2B | ||
| Q3 24 | $3.6B | $2.1B | ||
| Q2 24 | $3.5B | $2.0B |
负债/权益比CTOSMD
| Q1 26 | 0.03× | — | ||
| Q4 25 | 2.03× | 0.66× | ||
| Q3 25 | 2.10× | 0.65× | ||
| Q2 25 | 2.04× | 0.70× | ||
| Q1 25 | 1.97× | 0.75× | ||
| Q4 24 | 1.77× | 0.78× | ||
| Q3 24 | 1.87× | — | ||
| Q2 24 | 1.79× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $114.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CTOSMD
| Q1 26 | — | — | ||
| Q4 25 | $47.3M | $114.1M | ||
| Q3 25 | $81.5M | $137.3M | ||
| Q2 25 | $125.7M | $137.2M | ||
| Q1 25 | $55.6M | $-117.5M | ||
| Q4 24 | $82.1M | $133.0M | ||
| Q3 24 | $16.5M | $91.8M | ||
| Q2 24 | $37.8M | $107.0M |
现金转化率CTOSMD
| Q1 26 | — | — | ||
| Q4 25 | 2.27× | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | 2.98× | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTOS
| Equipment sales | $273.9M | 65% |
| Rental revenue | $116.3M | 28% |
| Parts sales and services | $32.1M | 8% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
